A detailed history of Sivia Capital Partners, LLC transactions in Bristol Myers Squibb CO stock. As of the latest transaction made, Sivia Capital Partners, LLC holds 4,292 shares of BMY stock, worth $244,815. This represents 0.12% of its overall portfolio holdings.

Number of Shares
4,292
Previous 3,882 10.56%
Holding current value
$244,815
Previous $201 Million 20.86%
% of portfolio
0.12%
Previous 0.12%

Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2024

Jan 13, 2025

BUY
$51.92 - $59.94 $21,287 - $24,575
410 Added 10.56%
4,292 $243 Million
Q3 2024

Oct 11, 2024

BUY
$39.66 - $51.75 $153,960 - $200,893
3,882 New
3,882 $201 Million

Others Institutions Holding BMY

About BRISTOL MYERS SQUIBB CO


  • Ticker BMY
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 2,126,160,000
  • Market Cap $121B
  • Description
  • Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, and markets biopharmaceutical products worldwide. It offers products for hematology, oncology, cardiovascular, immunology, fibrotic, neuroscience, and covid-19 diseases. The company's products include Revlimid, an oral immunomodulatory drug for the treatment of multiple my...
More about BMY
Track This Portfolio

Track Sivia Capital Partners, LLC Portfolio

Follow Sivia Capital Partners, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Sivia Capital Partners, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Sivia Capital Partners, LLC with notifications on news.